168 related articles for article (PubMed ID: 23721130)
21. Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo.
Nishimura T; Myles T; Piliponsky AM; Kao PN; Berry GJ; Leung LL
Blood; 2007 Mar; 109(5):1992-7. PubMed ID: 17105819
[TBL] [Abstract][Full Text] [Related]
22. Apoptotic and inflammatory signaling via Fas and tumor necrosis factor receptor I contribute to the development of chest trauma-induced septic acute lung injury.
Weckbach S; Hohmann C; Denk S; Kellermann P; Huber-Lang MS; Baumann B; Wirth T; Gebhard F; Bachem M; Perl M
J Trauma Acute Care Surg; 2013 Mar; 74(3):792-800. PubMed ID: 23425737
[TBL] [Abstract][Full Text] [Related]
23. Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein δ pathway.
Yan C; Ward PA; Wang X; Gao H
FASEB J; 2013 Aug; 27(8):2967-76. PubMed ID: 23585399
[TBL] [Abstract][Full Text] [Related]
24. Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.
Shao Z; Nishimura T; Leung LL; Morser J
J Thromb Haemost; 2015 Jun; 13(6):1090-102. PubMed ID: 25851247
[TBL] [Abstract][Full Text] [Related]
25. Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.
Russkamp NF; Ruemmler R; Roewe J; Moore BB; Ward PA; Bosmann M
FASEB J; 2015 Sep; 29(9):3762-72. PubMed ID: 25999468
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of CREMα in T cells aggravates lipopolysaccharide-induced acute lung injury.
Verjans E; Ohl K; Yu Y; Lippe R; Schippers A; Wiener A; Roth J; Wagner N; Uhlig S; Tenbrock K; Martin C
J Immunol; 2013 Aug; 191(3):1316-23. PubMed ID: 23785120
[TBL] [Abstract][Full Text] [Related]
27. Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin.
Colucci M; Pentimone A; Binetti BM; Cramarossa M; Piro D; Semeraro N
Thromb Haemost; 2002 Aug; 88(2):282-7. PubMed ID: 12195701
[TBL] [Abstract][Full Text] [Related]
28. Structure-function relationships in thrombin-activatable fibrinolysis inhibitor.
Plug T; Meijers JC
J Thromb Haemost; 2016 Apr; 14(4):633-44. PubMed ID: 26786060
[TBL] [Abstract][Full Text] [Related]
29. Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice.
Fujino N; Kubo H; Suzuki T; He M; Suzuki T; Yamada M; Takahashi T; Ota C; Yamaya M
Exp Lung Res; 2012 Feb; 38(1):28-36. PubMed ID: 22148910
[TBL] [Abstract][Full Text] [Related]
30. Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin.
Suda K; Eom J; Jaw JE; Mui T; Bai N; Or C; Ngan D; Li Y; Wang X; Tsuruta M; Tam S; Man SP; Van Eeden S; Sin DD
J Appl Physiol (1985); 2011 Oct; 111(4):1118-24. PubMed ID: 21778416
[TBL] [Abstract][Full Text] [Related]
31. Actin filament reorganization is a key step in lung inflammation induced by systemic inflammatory response syndrome.
Du L; Zhou J; Zhang J; Yan M; Gong L; Liu X; Chen M; Tao K; Luo N; Liu J
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):597-603. PubMed ID: 22721831
[TBL] [Abstract][Full Text] [Related]
32. Myeloid but not epithelial tissue factor exerts protective anti-inflammatory effects in acid aspiration-induced acute lung injury.
Kral-Pointner JB; Schrottmaier WC; Horvath V; Datler H; Hell L; Ay C; Niederreiter B; Jilma B; Schmid JA; Assinger A; Mackman N; Knapp S; Schabbauer G
J Thromb Haemost; 2017 Aug; 15(8):1625-1639. PubMed ID: 28509332
[TBL] [Abstract][Full Text] [Related]
33. Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease.
Fujimoto H; Gabazza EC; Hataji O; Yuda H; D'Alessandro-Gabazza CN; Nakano M; Franco OE; Hayashi T; Suzuki K; Adachi Y; Taguchi O
Am J Respir Crit Care Med; 2003 Jun; 167(12):1687-94. PubMed ID: 12615624
[TBL] [Abstract][Full Text] [Related]
34. Presence of thrombin-activatable fibrinolysis inhibitor in Helicobacter pylori-associated gastroduodenal disease.
Ikeda A; Gabazza EC; Morser J; Imoto I; Kuroda M; D'Alessandro-Gabazza CN; Hara K; Ruiz DB; Bernabe PG; Katsurahara M; Toda M; Kobayashi Y; Yano Y; Sumida Y; Suzuki K; Taguchi O; Takei Y
Helicobacter; 2009 Apr; 14(2):147-55. PubMed ID: 19298343
[TBL] [Abstract][Full Text] [Related]
35. [Thrombin activatable fibrinolysis inhibitor (TAFI) in allergic asthma patients].
Kemona-Chetnik I; Kowal K; Kucharewicz I; Pampuch A; Bodzenta-Lukaszyk A
Przegl Lek; 2006; 63(12):1281-5. PubMed ID: 17642140
[TBL] [Abstract][Full Text] [Related]
36. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice.
Chen J; Wang JB; Yu CH; Chen LQ; Xu P; Yu WY
J Ethnopharmacol; 2013 Jul; 148(3):835-41. PubMed ID: 23747643
[TBL] [Abstract][Full Text] [Related]
37. Transfusion-related acute lung injury in cardiac surgery patients is characterized by pulmonary inflammation and coagulopathy: a prospective nested case-control study.
Vlaar AP; Hofstra JJ; Determann RM; Veelo DP; Paulus F; Levi M; Zeerleder S; Vroom MB; Schultz MJ; Juffermans NP
Crit Care Med; 2012 Oct; 40(10):2813-20. PubMed ID: 22824931
[TBL] [Abstract][Full Text] [Related]
38. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
Stasko J; Hudecek J; Kubisz P
Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
[TBL] [Abstract][Full Text] [Related]
39. Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI).
Leung LL; Nishimura T; Myles T
Adv Exp Med Biol; 2008; 632():61-9. PubMed ID: 19025114
[TBL] [Abstract][Full Text] [Related]
40. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.
Colucci M; Binetti BM; Branca MG; Clerici C; Morelli A; Semeraro N; Gresele P
Hepatology; 2003 Jul; 38(1):230-7. PubMed ID: 12830006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
